BALOXAVIR

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H19F2N3O4S
Molecular Weight	483.487
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of BALOXAVIR

Structure Search

SMILES

[H][C@@]12COCCN1C(=O)C3=C(O)C(=O)C=CN3N2[C@@H]4C5=C(SCC6=C4C=CC(F)=C6F)C=CC=C5

InChI

InChIKey=FIDLLEYNNRGVFR-CTNGQTDRSA-N

InChI=1S/C24H19F2N3O4S/c25-16-6-5-13-15(20(16)26)12-34-18-4-2-1-3-14(18)21(13)29-19-11-33-10-9-27(19)24(32)22-23(31)17(30)7-8-28(22)29/h1-8,19,21,31H,9-12H2/t19-,21+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C24H19F2N3O4S
Molecular Weight	483.487
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 10:35:09 UTC 2023` Edited by `admin` on `Sat Dec 16 10:35:09 UTC 2023`
Record UNII	4G86Y4JT3F
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BALOXAVIR

Official Name

English

(12aR)-12-[(11S)-7,8-Difluoro-6,11-dihydrodibenzo[b,E]thiepin-11-yl]-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione

Systematic Name

English

S-033447

Code

English

1H-(1,4)OXAZINO(3,4-C)PYRIDO(2,1-F)(1,2,4)TRIAZINE-6,8-DIONE, 12-((11S)-7,8-DIFLUORO-6,11-DIHYDRODIBENZO(B,E)THIEPIN-11-YL)-3,4,12,12A-TETRAHYDRO-7-HYDROXY-, (12AR)-

Systematic Name

English

BALOXAVIR [MI]

Common Name

English

BALOXAVIR [USAN]

Common Name

English

Code System Code Type Description

DAILYMED

4G86Y4JT3F

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

RXCUI

2197842

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

CAS

1985605-59-1

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

SMS_ID

300000017206

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

LACTMED

Baloxavir

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

NCI_THESAURUS

C166756

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

USAN

FG-41

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

EPA CompTox

DTXSID101027860

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

DRUG BANK

DB15675

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

FDA UNII

4G86Y4JT3F

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

PUBCHEM

124081876

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

MERCK INDEX

m12107

Created by admin on Sat Dec 16 10:35:10 UTC 2023 , Edited by admin on Sat Dec 16 10:35:10 UTC 2023

PRIMARY

Related Record Type Details


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR


					0653B5V13T

INFLUENZA A VIRUS H3N2 WHOLE

TARGET ORGANISM->INHIBITOR

Qualification:

EC50

Amount:


					IHQ709299P

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A3

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					22ES734693

MULTIDRUG RESISTANCE PROTEIN 1

TRANSPORTER -> SUBSTRATE


					93O6C9VO2C

INFLUENZA A VIRUS H1N1 WHOLE

TARGET ORGANISM->INHIBITOR

Qualification:

EC50

Amount:


					6Z1X9E3UQD

INFLUENZA A VIRUS H5N1 WHOLE

TARGET ORGANISM->INHIBITOR

Qualification:

EC90

Amount:

Related Record Type Details


					CZU8BX4NFR

S-033447 PYRROLE

METABOLITE -> PARENT


					505CXM6OHG

BALOXAVIR MARBOXIL

PRODRUG -> METABOLITE ACTIVE

Related Record Type Details


					4G86Y4JT3F

BALOXAVIR

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

Tmax	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC